A personal perspective on medicinal and pharmaceutical chemistry.
作者信息
Banik Bimal K
机构信息
Department of Chemistry, The University of Texas-Pan American Edinburg, TX, USA.
出版信息
Front Chem. 2014 Feb 27;2:8. doi: 10.3389/fchem.2014.00008. eCollection 2014.
Abstract
摘要
相似文献
1
A personal perspective on medicinal and pharmaceutical chemistry.关于药物化学与制药化学的个人观点。
Front Chem. 2014 Feb 27;2:8. doi: 10.3389/fchem.2014.00008. eCollection 2014.
2
What Makes a Great Medicinal Chemist? A Personal Perspective.是什么造就了杰出的药物化学家？个人观点。
J Med Chem. 2018 Sep 13;61(17):7419-7424. doi: 10.1021/acs.jmedchem.7b01445. Epub 2018 May 22.
3
The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology.机器和自动化时代的药物化学：连续流动技术的最新进展。
J Med Chem. 2020 Jul 9;63(13):6624-6647. doi: 10.1021/acs.jmedchem.9b01956. Epub 2020 Feb 21.
4
Designer drugs: a medicinal chemistry perspective.设计药物：从药物化学角度来看。
Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17.
5
Medicinal Chemistry Aware Database GDBMedChem.医药化学意识数据库 GDBMedChem。
Mol Inform. 2019 Aug;38(8-9):e1900031. doi: 10.1002/minf.201900031. Epub 2019 Jun 6.
6
Unusual Amino Acids in Medicinal Chemistry.药物化学中的特殊氨基酸
J Med Chem. 2016 Dec 22;59(24):10807-10836. doi: 10.1021/acs.jmedchem.6b00319. Epub 2016 Sep 30.
7
The 12 AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey.第十二届土耳其伊斯坦布尔医科院国际药物化学研讨会（AIMECS 2019）
ChemMedChem. 2020 Jan 7;15(1):162-167. doi: 10.1002/cmdc.201900623. Epub 2019 Nov 14.
8
Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective.1 类 PI3K 临床候选药物和近期抑制剂设计策略：药物化学视角。
J Med Chem. 2019 May 23;62(10):4815-4850. doi: 10.1021/acs.jmedchem.8b01492. Epub 2018 Dec 24.
9
The 10th Joint Meeting on Medicinal Chemistry (JMMC 2017) Held in Dubrovnik, Croatia.第十届药物化学联合会议（JMMC2017）在克罗地亚杜布罗夫尼克举行。
ChemMedChem. 2018 Jan 8;13(1):116-119. doi: 10.1002/cmdc.201700713. Epub 2017 Dec 18.
10
Sustainable practices in medicinal chemistry: current state and future directions.药用化学中的可持续实践：现状和未来方向。
J Med Chem. 2013 Aug 8;56(15):6007-21. doi: 10.1021/jm400250p. Epub 2013 May 9.
本文引用的文献
1
Synthesis and biological evaluation of novel dibenzofluorene derivatives as anticancer agents.新型二苯并芴衍生物作为抗癌剂的合成及生物学评价
Oncol Lett. 2010 Mar;1(2):309-311. doi: 10.3892/ol_00000055. Epub 2010 Mar 1.
2
Asymmetric synthesis of anticancer β-lactams via Staudinger reaction.通过 Staudinger 反应进行抗癌 β-内酰胺的不对称合成。
Mol Med Rep. 2010 Mar-Apr;3(2):319-21. doi: 10.3892/mmr_00000259.
3
Selective anticancer activity of β-lactams derived from polyaromatic compound.多环芳烃衍生的β-内酰胺的选择性抗癌活性。
Mol Med Rep. 2010 Mar-Apr;3(2):315-6. doi: 10.3892/mmr_00000257.
4
Novel 6,12-disubstituted chrysene as potent anticancer agent: synthesis, in vitro and in vivo study.新型 6,12-二取代苝作为有效的抗癌剂：合成、体外和体内研究。
Eur J Med Chem. 2010 Oct;45(10):4687-91. doi: 10.1016/j.ejmech.2010.07.033. Epub 2010 Jul 24.
5
Remarkable iodine-catalyzed synthesis of novel pyrrole-bearing N-polyaromatic beta-lactams.显著的碘催化合成新型含吡咯的 N-多环β-内酰胺。
Molecules. 2010 Feb 23;15(2):1082-8. doi: 10.3390/molecules15021082.
6
Asymmetric synthesis of anticancer beta-lactams via Staudinger reaction: utilization of chiral ketene from carbohydrate.通过 Staudinger 反应不对称合成抗癌 β-内酰胺：利用碳水化合物衍生的手性烯酮。
Eur J Med Chem. 2010 Feb;45(2):846-8. doi: 10.1016/j.ejmech.2009.11.024. Epub 2009 Nov 18.
7
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
8
Promoting apoptosis as a strategy for cancer drug discovery.促进细胞凋亡作为癌症药物研发的一种策略。
Nat Rev Cancer. 2005 Nov;5(11):876-85. doi: 10.1038/nrc1736.
9
Stereocontrolled synthesis of anticancer beta-lactams via the Staudinger reaction.通过施陶丁格反应进行抗癌β-内酰胺的立体控制合成。
Bioorg Med Chem. 2005 Jun 1;13(11):3611-22. doi: 10.1016/j.bmc.2005.03.044.
10
Synthesis of anticancer beta-lactams: mechanism of action.抗癌β-内酰胺类药物的合成：作用机制
Bioorg Med Chem. 2004 May 15;12(10):2523-8. doi: 10.1016/j.bmc.2004.03.033.
Zotero 插件